Navigation Links
Impotence Drugs May Aid Brain Tumor Treatment
Date:5/12/2010

Levitra, Viagra allowed anti-cancer medication to more easily penetrate brain barrier, study found

WEDNESDAY, May 12 (HealthDay News) -- A drug already approved for the treatment of erectile dysfunction may actually help boost the effectiveness of treatments for brain tumors tied to both lung and breast cancer, research shows.

The finding stems from an animal study that indicated that leading erectile dysfunction medications sildenafil (Viagra) and vardenafil (Levitra) can enable the chemotherapy drug Herceptin to more easily penetrate the so-called blood-brain barrier that must be breached in order to successfully target cancer that has spread to the brain.

Although the blood-brain barrier is a naturally occurring mechanism designed to protect the brain from exposure to dangerous substances, in the case of cancer treatment it can significantly impede drug delivery, particularly of large-molecule drugs, such as Herceptin. However, erectile dysfunction drugs appear to increase the barrier's permeability.

"No matter how effective against cancer a chemotherapeutic agent may be, it can have little impact on brain tumors if it cannot cross the blood-brain tumor barrier," Dr. Keith Black, chairman of Cedars-Sinai's department of neurosurgery and director of the Maxine Dunitz Neurosurgical Institute in Los Angeles, said in a news release. "As we find new drugs that are able to target these tumor cells, it is imperative that we develop better ways to enable the medications to reach their targets."

The study team notes that about 220,000 Americans develop brain tumors each year as a result of cancers that begin elsewhere in the body. Lung cancer, they note, is the leading cause of cancer mortality in the United States, and about one-fifth of lung cancer cases end up spreading to the brain.

Work with mice demonstrated that initial Levitra exposure effectively doubled the amount of Herceptin that was able to reach brain tumors linked to lung and breast cancer.

What's more, when administering Herceptin and Levitra together, survival among the mice increased by 20 percent compared to treatment with just Herceptin alone.

The findings were published online recently in the journal PLoS One.

More Information

For more on brain tumors, visit the U.S. National Cancer Institute.



-- Alan Mozes



SOURCE: Cedars-Sinai Medical Center, news release, May 7, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Monitoring and control can limit side effects of promising cancer drugs
2. Parkinsons Drugs Tied to Compulsive Behaviors
3. Stomach Acid Drugs Come with Dangers, Studies Show
4. Anemia Drugs Hold Dangers for Kidney Patients
5. As FDA Eyes Prostate Cancer Drugs, Experts Urge Caution
6. Taking Flu Drugs While Pregnant Appears to Be Safe: Study
7. OTC Drugs May Work Differently in Obese Kids
8. Study finds that drugs used for treatment of influenza in pregnancy appear to be safe
9. BATTLE links potential biomarkers to drugs for lung cancer
10. Matching Tumor Types to Drugs Boosts Lung Cancer Outcomes
11. Cholesterol Drugs May Slow MS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... April 29, 2016 , ... ... Footwear Foundation, the national charitable foundation serving the footwear industry, has broken all ... representing more than 130 companies across 23 states during the months of April ...
(Date:4/29/2016)... Georgia (PRWEB) , ... April 29, 2016 , ... On ... rural hospitals across the Southeast, celebrated the signature of Gov. Nathan Deal on SB ... Rep. Geoff Duncan (R - Cumming), offers a 70% tax credit to individuals and ...
(Date:4/29/2016)... STAMFORD, CONNECTICUT (PRWEB) , ... April 29, 2016 , ... ... 5K Run/Walk” at Cove Island Park on Sunday, with sunny skies, a light breeze ... event, raising nearly $33,000. , The 5k Run and Walk and 1-mile ...
(Date:4/29/2016)... ... April 29, 2016 , ... The Wharton School of ... Grand Prize of the 2016 Wharton Business Plan Competition —as well as ... Award, and the Committee Award for Most ‘Wow Factor,’ making them the first ...
(Date:4/29/2016)... , ... April 29, 2016 , ... Melanoma is the deadliest type of skin cancer. ... for the majority of skin cancer deaths. More than 10,000 people are expected to die ... diagnosis is 62, it is the one of the most commonly diagnosed cancers in young ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... Dr. ... und Stephen Schmidt werden Teil ... ein führender Anbieter cloudbasierter Softwarelösungen für den ... neue Führungskräfte zum Team Sicherheit und Pharmakovigilanz ... Erfahrungen mitbringen.  Dies wird die Geschäftseinheit Sicherheit ...
(Date:4/28/2016)... , April 28, 2016 Oramed Pharmaceuticals ... clinical-stage pharmaceutical company focused on the development of oral drug ... the upcoming PIONEERS 2016 conference, presented by Joseph Gunnar ... in New York . Nadav Kidron ... the conference. Presentation Details:   ...
(Date:4/27/2016)...  Hologic, Inc. (Nasdaq: HOLX ) ... fiscal second quarter ended March 26, 2016.  GAAP ... 41.2%, and non-GAAP diluted EPS of $0.47 increased ... a reported basis, and 6.3% on a constant ... good quarter, highlighted by 14.6% growth in non-GAAP ...
Breaking Medicine Technology: